FLUOTHANE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fluothane, and when can generic versions of Fluothane launch?
Fluothane is a drug marketed by Wyeth Ayerst and is included in one NDA.
The generic ingredient in FLUOTHANE is halothane. There are four drug master file entries for this compound. Additional details are available on the halothane profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FLUOTHANE?
- What are the global sales for FLUOTHANE?
- What is Average Wholesale Price for FLUOTHANE?
Summary for FLUOTHANE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 72 |
| Clinical Trials: | 1 |
| Patent Applications: | 3,138 |
| DailyMed Link: | FLUOTHANE at DailyMed |
Recent Clinical Trials for FLUOTHANE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Nanjing Medical University | N/A |
US Patents and Regulatory Information for FLUOTHANE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Ayerst | FLUOTHANE | halothane | LIQUID;INHALATION | 011338-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
